Published in Clinical Oncology Week, April 13th, 2009
"The adoptive Th1 cell therapy has been shown to be an attractive strategy for inducing tumor eradication in mouse systems. However, Th1-cell therapy using human tumour-specific Th1 cells, which were expanded...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.